Development of an algorithm for identifying rheumatoid arthritis in the Korean National Health Insurance claims database
이의경
RHEUMATOLOGY INTERNATIONAL, 201312
132
Analyses of Direct and Indirect Impacts of a Positive List System on Pharmaceutical R&D Investments
김태현, 이의경, 정명진, 한은아
CLINICAL THERAPEUTICS, 201307
133
Evaluation of the pilot program on the real-time drug utilization review system in South Korea
김석일, 서동철, 이의경, 허지행
INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 201307
134
Socio-demographic factors influencing the use of injections in South Korean outpatient care
이의경
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 201301
135
Medical costs for Korean patients with rheumatoid arthritis based on the national claims database
권정미, 김진희, 이의경, 조수경
RHEUMATOLOGY INTERNATIONAL, 201209
136
A Comparison of Preferences of Targeted Therapy for Metastatic Renal Cell Carcinoma between the Patient Group and Health Care Professional Group in South Korea
이의경
VALUE IN HEALTH, 201209
137
Clinical and Cost Effectiveness of Bevacizumab plus FOLFIRI Combination Versus FOLFIRI Alone as First-Line Treatment of Metastatic Colorectal Cancer in South Korea
이의경
CLINICAL THERAPEUTICS, 201206
138
Eliciting Public Preference for Health-Care Resource Allocation in South Korea
배은영, 이의경, 이태진, 임민경, 최상은
VALUE IN HEALTH, 201201
139
Different Policy Outcomes of the New Drugs and Currently Listed Drugs under the Positive List System in South Korea
김보연, 박미혜, 이의경, 임재영
VALUE IN HEALTH, 201201
140
Evaluation of Cost-Utility of Varenicline Compared with Existing Smoking Cessation Therapies in South Korea